Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration

被引:295
作者
Rajalingam, K
Wunder, C
Brinkmann, V
Churin, Y
Hekman, M
Sievers, C
Rapp, UR
Rudel, T
机构
[1] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany
[2] Microscopy Core Facil, D-10117 Berlin, Germany
[3] Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany
关键词
D O I
10.1038/ncb1283
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ras proteins control the signalling pathways that are responsible for normal growth and malignant transformation(1). Raf protein kinases are direct Ras effector proteins that initiate the mitogen-activated protein kinase (MAPK) cascade(2), which mediates diverse biological functions such as cell growth, survival and differentiation(3). Here we show that prohibitin, a ubiquitously expressed and evolutionarily conserved protein(4) is indispensable for the activation of the Raf-MEK-ERK pathway by Ras. The membrane targeting and activation of C-Raf by Ras needs prohibitin in vivo. In addition, direct interaction with prohibitin is required for C-Raf activation. C-Raf kinase fails to interact with the active Ras induced by epidermal growth factor in the absence of prohibitin. Moreover, in prohibitin-deficient cells the adhesion complex proteins cadherin and beta-catenin relocalize to the plasma membrane and thereby stabilize adherens junctions. Our data show an unexpected role of prohibitin in the activation of the Ras-Raf signalling pathway and in modulating epithelial cell adhesion and migration.
引用
收藏
页码:837 / 843
页数:7
相关论文
共 31 条
[1]   PROHIBITIN GENE IS OVEREXPRESSED BUT NOT MUTATED IN RAT BLADDER CARCINOMAS AND CELL-LINES [J].
ASAMOTO, M ;
COHEN, SM .
CANCER LETTERS, 1994, 83 (1-2) :201-207
[2]   Ras activation of the Raf kinase: Tyrosine kinase recruitment of the MAP kinase cascade [J].
Avruch, J ;
Khokhlatchev, A ;
Kyriakis, JM ;
Luo, ZJ ;
Tzivion, G ;
Vavvas, D ;
Zhang, XF .
RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 :127-155
[3]   SERUM-INDUCED, TPA-INDUCED, AND RAS-INDUCED EXPRESSION FROM AP-1/ETS-DRIVEN PROMOTERS REQUIRES RAF-1 KINASE [J].
BRUDER, JT ;
HEIDECKER, G ;
RAPP, UR .
GENES & DEVELOPMENT, 1992, 6 (04) :545-556
[4]   Regulation of Raf-1 activation and signalling by dephosphorylation [J].
Dhillon, AS ;
Meikle, S ;
Yazici, Z ;
Eulitz, M ;
Kolch, W .
EMBO JOURNAL, 2002, 21 (1-2) :64-71
[5]   Targeting ras signalling pathways in cancer therapy [J].
Downward, J .
NATURE REVIEWS CANCER, 2003, 3 (01) :11-22
[6]   Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras [J].
Dumaz, N ;
Marais, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (32) :29819-29823
[7]   Timeline - The discovery of receptor tyrosine kinases: targets for cancer therapy [J].
Gschwind, A ;
Fischer, OM ;
Ullrich, A .
NATURE REVIEWS CANCER, 2004, 4 (05) :361-370
[8]   Molecular mechanisms underlying ErbB2/HER2 action in breast cancer [J].
Harari, D ;
Yarden, Y .
ONCOGENE, 2000, 19 (53) :6102-6114
[9]   Associations of B- and C-raf with cholesterol, phosphatidylserine, and lipid second messengers - Preferential binding of Raf to artificial lipid rafts [J].
Hekman, M ;
Hamm, H ;
Villar, AV ;
Bader, B ;
Kuhlmann, J ;
Nickel, J ;
Rapp, UR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) :24090-24102
[10]   Dynamic changes in C-raf phosphorylation and 14-3-3 protein binding in response to growth factor stimulation - Differential roles of 14-3-3 protein binding sites [J].
Hekman, M ;
Wiese, S ;
Metz, R ;
Albert, S ;
Troppmair, J ;
Nickel, J ;
Sendtner, M ;
Rapp, UR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (14) :14074-14086